In addition, serum ALB levels were significantly reduced in the model group (p < 0.05), whereas serum ALT, AST, TBIL, and γ-GGT levels, which were used to evaluate hepatocellular necrosis and cholestasis associated with hepatic fibrosis, were drastically increased compared to the control group. The gene discussed is ALB; the disease is Hepatic fibrosis.